MCCORMICK FRANK

CIK 00012578095 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001257809

Recent Transactions

50 trades

Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-10-29$66.20/sh−31,116→ 735,467 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-10-29$67.52/sh−3,497→ 731,970 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-10-29$69.24/sh−43,393→ 679,979 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-10-29$65.48/sh−111,755→ 766,583 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-10-29$68.50/sh−8,598→ 723,372 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-10-27$65.00/sh−1,641→ 878,338 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-09-05$11.92/sh+74,000→ 157,275 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2025-09-05−74,000→ 84,814 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-09-05$53.16/sh−74,000→ 83,275 total
Award
BridgeBio Oncology Therapeutics, Inc.$BBOT
Stock Option (Right to Buy)
2025-08-26+91,076→ 91,076 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-06-24$44.23/sh−100,000→ 879,979 total
Award
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-06-20+6,589→ 83.275 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2025-06-20+8,425→ 8,425 total
Gift
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-05-08−3,000→ 76,686 total
Gift
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-05-07−33,000→ 79,686 total
Gift
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-12-26−7,400→ 112,686 total
Gift
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-12-26−7,400→ 464,976 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2024-06-21+26,014→ 26,014 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2023-12-26$42.06/sh−100,000→ 627,689 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2023-02-21+158,814→ 158,814 total
Conversion
Olema Pharmaceuticals, Inc.$OLMA
Common Stock
2020-11-23+66,326→ 84,260 total
Conversion
Olema Pharmaceuticals, Inc.$OLMA
Series A-1 Convertible Preferred Stock
2020-11-23−152,891→ 0 total
Conversion
Olema Pharmaceuticals, Inc.$OLMA
Series A Convertible Preferred Stock
2020-11-23−66,326→ 0 total
Conversion
Olema Pharmaceuticals, Inc.$OLMA
Common Stock
2020-11-23+152,891→ 191,113 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (Right to Buy)
2020-11-18+21,520→ 21,520 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-11-13$42.22/sh−31,632→ 1,268,836 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-11-13$42.91/sh−58,299→ 1,210,537 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-11-13$43.57/sh−10,069→ 1,200,468 total
Award
Olema Pharmaceuticals, Inc.$OLMA
Stock Option (Right to Buy)
2020-09-18+56,964→ 56,964 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2020-05-19+10,549→ 10,549 total
Award
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-05-19+39,042→ 1,300,568 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2019-12-30$36.86/sh−900→ 1,261,526 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2019-12-30$35.74/sh−16,250→ 1,262,426 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2019-12-27$36.85/sh−21,656→ 1,314,239 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2019-12-27$42.93/sh−100→ 1,278,576 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2019-12-27$36.37/sh−25,531→ 1,335,895 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2019-12-27$38.09/sh−3,500→ 1,310,739 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2019-12-27$42.26/sh−617→ 1,278,676 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2019-12-27$41.31/sh−883→ 1,279,293 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2019-12-27$40.13/sh−16,858→ 1,280,176 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2019-12-27$39.27/sh−13,705→ 1,297,034 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2019-07-01+290,476→ 1,361,426 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Units
2019-07-01−132,317→ 0 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Series B Units
2019-07-01−66,729→ 0 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Management Incentive Units
2019-07-01−418,016→ 0 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2019-07-01+418,016→ 1,070,950 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Units
2019-07-01−47,165→ 0 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2019-07-01+66,729→ 246,211 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2019-07-01+47,165→ 47,165 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Management Incentive Units
2019-07-01−406,723→ 0 total

Companies

Recent Filings

Address

C/O EXELIXIS, INC. 249 EAST GRAND AVE., PO BOX 511

SOUTH SAN FRANCISCO, CA, 94083-0511

View on SEC.gov